Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYRANO: Advagraf Dosing Based on CYP3A5 Genotype in Kidney Transplant
NCT02311010Phase 4Unknown
- Sponsor
- UCLouvain
- Start
- Jan 2011
- Primary completion
- Oct 2014
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplantation, sponsored by UCLouvain. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT02311010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02311010.